Results 81 to 90 of about 414,372 (151)

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Central and Southern Tunisia cohort of the A 1 chieve study

Indian Journal of Endocrinology and Metabolism, 2013
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical care ...
Mohamed Abid, Ines Khochtali
doaj   +1 more source

Clinical experience with insulin detemir type 2 diabetes mellitus, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Rabat-Sale-Zemmour-Zaer Region cohort of the A 1 chieve study

Indian Journal of Endocrinology and Metabolism, 2013
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66 726) in routine clinical care ...
Abdelmjid Chraibi, Ghizlane Belmejdoub
doaj   +1 more source

Comparative pharmacokinetics and pharmacodynamics of the novel rapid- acting insulin analogue, insulin aspart, in healthy volunteers

Objective: The pharmacokinetics of a new insulin analogue, insulin aspart, were compared with unmodified human insulin in a double-blind crossover study of 25 fasting healthy men following a single subcutaneous dose.
Home PD; Barriocanal L; Lindholm A
core   +4 more sources

Effects of insulin aspart and metformin on gestational diabetes mellitus and inflammatory markers. [PDF]

World J Diabetes, 2023
Wang Y, Song M, Qi BR.
europepmc   +1 more source

A Comparison of Faster Insulin Aspart with Standard Insulin Aspart Using Hybrid Automated Insulin Delivery System in Active Children and Adolescents with Type 1 Diabetes: A Randomized Double-Blind Crossover Trial. [PDF]

Diabetes Technol Ther, 2023
Dovc K, Bergford S, Fröhlich-Reiterer E, Zaharieva DP, Potocnik N, Müller A, Lenarcic Z, Calhoun P, Fritsch M, Sourij H, Bratina N, Kollman C, Battelino T.   +12 more
europepmc   +1 more source

Cost-effectiveness of insulin degludec/insulin aspart versus biphasic insulin aspart in Chinese population with type 2 diabetes. [PDF]

Front Public Health, 2022
Luo Q, Zhou L, Zhou N, Hu M.
europepmc   +1 more source

Cardioprotective role of insulin: Advantage analogues

Journal of Research in Medical Sciences, 2012
Aim: Type II diabetes mellitus (DM) increases the risk of cardiovascular disease. Treatment with insulin substantially reduces C - reactive protein (CRP) because of its anti-atherosclerotic action.
Rituparna Maiti, Jyothirmai Jaida, Pulukuri John Israel Leander, Mohammed Irfanuddin, Idris Ahmed, Anuradha Palani   +5 more
doaj  

Faster Insulin Aspart for Continuous Subcutaneous Insulin Infusion: Is It Worth It? [PDF]

Cureus, 2022
Rosinha P, Teixeira S, Vilaverde J, Cardoso MH.   +3 more
europepmc   +1 more source

Practical guide in using insulin degludec/insulin aspart: A multidisciplinary approach in Malaysia. [PDF]

Malays Fam Physician, 2023
Chan SP, Mumtaz M, Ratnasingam J, Tan ATB, Lim SC, Rosman A, Chee KH, Lim SK, Yew SS, Mohd Yusof BN, Lau BK, Kassim SB, Mohamed M.   +12 more
europepmc   +1 more source

Protocol to Assess the Biological Activity of Insulin Glargine, Insulin Lispro, and Insulin Aspart In Vitro. [PDF]

Methods Protoc, 2023
Garige M, Ghosh S, Roelofs B, Rao VA, Sourbier C.   +4 more
europepmc   +1 more source